# Analgesic Effect of Oxytocin Receptor Modulation

> **NCT01918475** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 25 (actual)

## Conditions studied

- Pain
- Hyperalgesia
- Central Sensitization

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01918475
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918475, "Analgesic Effect of Oxytocin Receptor Modulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01918475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*